[Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties]
- PMID: 8134502
[Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties]
Abstract
Pharmacokinetic properties of tricyclic antidepressants (TCA) and factors changing pharmacokinetics of these drugs were presented. The following factors were discussed: age, genetically determined rate of metabolism and TCA interaction with co-administered drugs. As a consequence of these factors alterations mainly in elimination of TCA are observed. It leads to large interindividual variation in TCA plasma concentrations and lack of correlation between TCA concentration and dosage.
Similar articles
-
[Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].Psychiatr Pol. 1994 Jan-Feb;28(1):17-26. Psychiatr Pol. 1994. PMID: 8190816 Polish.
-
[Therapeutic monitoring of tricyclic antidepressant drugs].Psychiatr Pol. 2003 Sep-Oct;37(5):825-37. Psychiatr Pol. 2003. PMID: 14631602 Review. Polish.
-
Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.J Clin Psychiatry. 1985 Oct;46(10):418-24. J Clin Psychiatry. 1985. PMID: 3900052 Review.
-
Plasma concentrations of tricyclic antidepressants in clinical practice.J Clin Psychiatry. 1982 Feb;43(2):66-9. J Clin Psychiatry. 1982. PMID: 7056706
-
Lithium and tricyclic antidepressants.Psychiatr Clin North Am. 1992 Mar;15(1):223-4. Psychiatr Clin North Am. 1992. PMID: 1549546 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials